Works matching IS 00778923 AND DT 2014 AND VI 1329 AND IP 1

Results: 8

Development of onabotulinumtoxinA for chronic migraine.

Published in:

Annals of the New York Academy of Sciences, 2014, v. 1329, n. 1, p. 67, doi. 10.1111/nyas.12488

By:

Whitcup, Scott M.;
Turkel, Catherine C.;
DeGryse, Ronald E.;
Brin, Mitchell F.

Publication type:

Article

Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.

Published in:

Annals of the New York Academy of Sciences, 2014, v. 1329, n. 1, p. 1, doi. 10.1111/nyas.12550

By:

Sanghera, Rick;
Sanders, Richard;
Husby, Michael;
Bentsen, James G.

Publication type:

Article

Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome.

Published in:

Annals of the New York Academy of Sciences, 2014, v. 1329, n. 1, p. 45, doi. 10.1111/nyas.12508

By:

Benitez, Arturo;
Edens, Heather;
Fishman, Jesse;
Moran, Kimberly;
Asgharnejad, Mahnaz

Publication type:

Article

Development of the Trevo ProVue Retriever for intracranial clot removal in acute ischemic stroke.

Published in:

Annals of the New York Academy of Sciences, 2014, v. 1329, n. 1, p. 107, doi. 10.1111/nyas.12579

By:

Prince, Heather C.;
Saliba, Amelia J.;
Wheeler, Jaime;
Bruder, Scott

Publication type:

Article

Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia.

Published in:

Annals of the New York Academy of Sciences, 2014, v. 1329, n. 1, p. 81, doi. 10.1111/nyas.12496

By:

Salzer, Wanda L.;
Asselin, Barbara L.;
Plourde, Paul V.;
Corn, Tim;
Hunger, Stephen P.

Publication type:

Article

Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation.

Published in:

Annals of the New York Academy of Sciences, 2014, v. 1329, n. 1, p. 93, doi. 10.1111/nyas.12567

By:

Hanna, Michael S.;
Mohan, Puneet;
Knabb, Robert;
Gupta, Elora;
Frost, Charles;
Lawrence, John H.

Publication type:

Article

Development of dalfampridine, a novel pharmacologic approach for treating walking impairment in multiple sclerosis.

Published in:

Annals of the New York Academy of Sciences, 2014, v. 1329, n. 1, p. 33, doi. 10.1111/nyas.12512

By:

Blight, Andrew R.;
Henney, Herbert R.;
Cohen, Ron

Publication type:

Article

Advances in epilepsy treatment: lacosamide pharmacokinetic profile.

Published in:

Annals of the New York Academy of Sciences, 2014, v. 1329, n. 1, p. 18, doi. 10.1111/nyas.12513

By:

Cawello, Willi;
Stockis, Armel;
Andreas, Jens‐Otto;
Dimova, Svetlana

Publication type:

Article